https://www.selleckchem.com/pr....oducts/d-luciferin.h
The emergence and efficacy of chimeric antigen receptor (CAR) T cell therapy in previously incurable malignancies represents a promising paradigm shift in cancer care. However, it is not without significant clinical, operational, and financial considerations. Pharmacists should be prepared to fulfill the various roles in CAR T cell therapy provision including policy development; electronic medical record build; patient and staff education; patient selection; procurement, storage, and handling; medication administration and supportiv
Like
Comment
Share
